Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Common supplement protocols pair a NAD+ precursor such as nicotinamide riboside or NMN at roughly 250 to 500 mg daily with liposomal or reduced glutathione at about 250 to 500 mg daily, usually taken in the morning on an empty stomach, while IV or injectable protocols use very different amounts on a clinician-set schedule. There is no single officially established combined dose, and the right amount varies with your age, liver and kidney function, existing medications, and whether you are addressing fatigue, oxidative stress, or recovery, so several factors need to be weighed before you start. Timing, cycling, and warning signs of taking too much are covered below, along with details you should review before choosing a dose.
Because dosing depends heavily on your own symptoms and health history, it helps to clarify what your body is actually signaling before adding stacked supplements. You can take a free, instant, online symptom check to better understand what may be driving how you feel and get guidance on sensible next steps.
Last reviewed for medical accuracy: 09/14/2026
NAD+ (nicotinamide adenine dinucleotide) and glutathione are two key molecules that support cellular energy, DNA repair and antioxidant defense. When used together, they can reinforce each other’s benefits—often referred to as NAD+ and glutathione synergy. Below is a practical guide to dosing both safely, based on clinical data and expert consensus.
NAD+
Glutathione
Clinical studies show that boosting NAD+ can help cells generate more energy, while adequate glutathione prevents oxidative damage. Together they support mitochondrial health and resilience.
| Supplement | Common Dose | Notes |
|---|---|---|
| NAD+ Precursors | NR 250–500 mg once or twice daily NMN 250–300 mg once or twice daily |
Split doses with meals to improve absorption. |
| Reduced Glutathione (GSH) | 250–500 mg once daily Up to 500 mg twice daily in high-stress situations |
Liposomal forms may boost bioavailability. |
| N-Acetyl Cysteine (NAC) | 600 mg twice daily | Precursor to glutathione; alternative if GSH not tolerated. |
| Protocol Component | Dose Range | Frequency |
|---|---|---|
| NAD+ | 100–300 mg per infusion | Weekly to monthly, depending on goals |
| Glutathione (GSH) | 600–2,400 mg per infusion | Often paired with NAD+ |
IV therapy is typically administered under medical supervision and may offer faster, more complete absorption.
When pairing NAD+ and glutathione:
Start Low and Go Slow
Split Doses
Maintain Balance
Cycle or Adjust
Whenever starting a new supplement regimen, keep a journal of any changes in energy, mood or digestion. This helps you and your doctor fine-tune doses.
To maximize NAD+ and glutathione synergy, consider:
While many people tolerate these supplements well, certain symptoms warrant prompt attention. If you experience:
…you should seek emergency care immediately. For non-emergency concerns—such as chronic fatigue, unexplained weight change or digestive disturbances—you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.
This guide provides a framework, but individual needs vary. Always speak to a doctor before beginning or adjusting any supplement regimen—especially if you have underlying health conditions or take prescription medications.
(References)
* Sperry JF, Robertson DC. Erythritol catabolism by Brucella abortus. J Bacteriol. 1975 Feb;121(2):619-30. doi: 10.1128/jb.121.2.619-630.1975. PMID: 163226; PMCID: PMC245974.
* ROST J, RAPOPORT S. REDUCTION-POTENTIAL OF GLUTATHIONE. Nature. 1964 Jan 11;201:185. doi: 10.1038/201185a0. PMID: 14118271.
* Janků M, Tichá T, Luhová L, Petřivalský M. Measurement of S-Nitrosoglutathione Reductase Activity in Plants. Methods Mol Biol. 2020;2057:45-59. doi: 10.1007/978-1-4939-9790-9_5. PMID: 31595469.
* Kang SO, Kwak MK. Alcohol dehydrogenase 1 and NAD(H)-linked methylglyoxal oxidoreductase reciprocally regulate glutathione-dependent enzyme activities in Candida albicans. J Microbiol. 2021 Jan;59(1):76-91. doi: 10.1007/s12275-021-0552-7. Epub 2020 Dec 23. PMID: 33355888.
* Aljaser FS, Ghneim HK, ALshubaily MM, Abudawood M, Almajed F, Fatima S, ALsheikh YA. Glutathione and oxidized nicotinamide adenine dinucleotide (NAD(+)) redox status in plasma and placental tissue of Saudi patients with intrauterine growth restriction. Saudi Med J. 2021 May;42(5):491-498. doi: 10.15537/smj.2021.42.5.20200685. PMID: 33896778; PMCID: PMC9149688.
* Oka SI, Byun J, Huang CY, Imai N, Ralda G, Zhai P, Xu X, Kashyap S, Warren JS, Alan Maschek J, Tippetts TS, Tong M, Venkatesh S, Ikeda Y, Mizushima W, Kashihara T, Sadoshima J. Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy. Circ Res. 2021 Jun 25;129(1):114-130. doi: 10.1161/CIRCRESAHA.120.317943. Epub 2021 Apr 30. PMID: 33928788; PMCID: PMC8513534.
* Ma Y, Zhu S, Yi M, Zhang W, Xue Y, Liu X, Deng H. Profiling Glutathionylome in CD38-Mediated Epithelial-Mesenchymal Transition. J Proteome Res. 2022 May 6;21(5):1240-1250. doi: 10.1021/acs.jproteome.1c00893. Epub 2022 Apr 14. PMID: 35420434.
* Yang M, Tsui MG, Tsang JKW, Goit RK, Yao KM, So KF, Lam WC, Lo ACY. Involvement of FSP1-CoQ(10)-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis. Cell Death Dis. 2022 May 18;13(5):468. doi: 10.1038/s41419-022-04924-4. Epub 2022 May 18. PMID: 35585057; PMCID: PMC9117320.
* Nakamura T, Hipp C, Santos Dias Mourão A, Borggräfe J, Aldrovandi M, Henkelmann B, Wanninger J, Mishima E, Lytton E, Emler D, Proneth B, Sattler M, Conrad M. Phase separation of FSP1 promotes ferroptosis. Nature. 2023 Jul;619(7969):371-377. doi: 10.1038/s41586-023-06255-6. Epub 2023 Jun 28. PMID: 37380771; PMCID: PMC10338336.
* Lawal TA, Riekhof W, Groom L, Varma P, Chrismer IC, Kokkinis A, Grunseich C, Witherspoon JW, Razaqyar MS, Sinaii N, Meilleur KG, Xiang L, Buzkova J, Euro L, Mohassel P, Dirksen RT, Todd JJ. NAD(+) dyshomeostasis in RYR1-related myopathies. Skelet Muscle. 2025 Aug 22;15(1):22. doi: 10.1186/s13395-025-00390-6. Epub 2025 Aug 22. PMID: 40846977; PMCID: PMC12374369.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.